Bioinformatics Market Developments and Forecast by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Bioinformatics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Bioinformatics Platforms, Knowledge Management Tools, and Bio Informative Services), Application (Genomics, Proteomics, Chemoinformatics & Drug Design, Transcriptomics, Metabolomics, and Others), and Sector (Medical Biotechnology, Animal Biotechnology, Agricultural Biotechnology, Academics, Environmental Biotechnology, Forensic Biotechnology, and Others)

  • Report Date : Aug 2022
  • Report Code : TIPRE00003993
  • Category : Technology, Media and Telecommunications
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 206

[Research Report] The bioinformatics market is expected to grow from US$ 12,609.39 million in 2021 to US$ 34,749.78 million by 2028; it is estimated to grow at a CAGR of 15.7% from 2022 to 2028.

Market Insights and Analyst View:

Bioinformatics is the application of information technology to manage biological data that helps in decoding plant genomes. The bioinformatics stores, analyses and interprets the big data generated by life-science experiments, or collected in a clinical context. This multidisciplinary field is driven by experts from a variety of backgrounds including biologists, computer scientists, mathematicians, statisticians and physicists. Bioinformatics allows researchers to perform experiments on a timeline that matters in a person’s lifetime. For example, during the coronavirus pandemic, researchers were able to sequence the virus’s genome, identify what was likely to be causing the virus to enter cells, and develop a vaccine based on the discovered genome within a matter of months. Additional bioinformatic approaches are being used to identify and treat other diseases like diabetes and cancer. The growth of the bioinformatics market is attributed to the increasing funding and investments in bioinformatics, and increased number of genomic research activities with corresponding adoption of bioinformatics are expected to propel the bioinformatics market growth during the forecast period.

Growth Drivers and Challenges:

In the field of genetics and genomics, the bioinformatics aids in sequencing and annotating genomes. Bioinformatics plays a role in the analysis of gene and protein expression and regulation. Bioinformatics tools aid in the comparison of genetic and genomic data and more generally in the understanding of evolutionary aspects of molecular biology. The role of human genomics research and related biotechnologies has the potential to achieve several public health goals, such as to reduce global health inequalities by providing developing countries with efficient, cost-effective, and robust means of preventing, diagnosing, and treating major diseases that burden their populations. Currently, cancer treatment is also set to gain from genomic information to predict how an individual responds to drugs and inform prescription of the appropriate drug or dosage.

The initiatives to generate and collect human genomic data is evolving rapidly and is highly diverse, with private and public initiatives across multiple countries. Since 1990, the cost of sequencing a whole genome dropped from US$ 2.7 million to as low as US$ 300, opening new opportunities to build repositories of genomic data. By the start of 2020, there were 187 genomic initiatives globally of which 50% originated in the U.S. and 19% in Europe. Thirty-eight million genomes had been analyzed using techniques ranging from genotyping to whole genome sequencing, and this number is expected to grow to 52 million by 2025. Therefore, the increasing number of genomics activities along with rising adoption of bioinformatics is driving the market.

One of the challenges is that bioinformatics is a collection of different fields – structural biology, genomics, chemical biology, etc – and they’re all moving very quickly. New techniques are coming online almost daily, there are lots of new data types, so keeping up with the deluge of new things is very difficult.  

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Bioinformatics Market: Strategic Insights

bioinformatics-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Report Segmentation and Scope:

The “Global Bioinformatics Market” is segmented based on product, application, sector, and geography. Based on the product, the bioinformatics market is segmented into bioinformatics platforms, knowledge management tools, and bioinformative services. Based on application, the bioinformatics market is segmented into genomics, proteomics, chemoinformatics & drug design, transcriptomics, metabolomics, and others. Based on sector, the bioinformatics market is divided into medical biotechnology, animal biotechnology, agricultural biotechnology, academics, environmental biotechnology, forensic biotechnology, and others. The bioinformatica market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)

Segmental Analysis:

The bioinformatics market is segmented based on product into bioinformatics platforms, knowledge management tools, and bioinformative services. The bioinformatics platforms segment held the largest market share in 2021; however, knowledge management tools are anticipated to register the highest CAGR during the forecast period. The major driving factor for the growth of this segment is the increasing number of more advanced and automated product developments and growing availability in the lower-middle income countries. Developments in the bioinformatics platforms have helped the bioinformatics market to grow significantly. For instance, in August 2022, Predicine launched its CE-marked PredicineCARE for genomic profiling in blood and urine in Europe. The cell-free DNA (cfDNA) assay is a targeted next-generation sequencing (NGS) assay for detecting single nucleotide variants, insertions and deletions, DNA rearrangements, and copy number variations in patients diagnosed with cancer. The assay has been used in clinical trials, patient testing, and the development of companion diagnostics.

Based on application, the bioinformatics market is segmented into genomics, proteomics, chemoinformatics & drug design, transcriptomics, metabolomics, and others. The genomics segment held the largest market share in 2021; however, chemoinformatics and drug design are anticipated to register the highest CAGR in the market during the forecast period. Due to innovative product developments and rising research in the sector segments, the segment's growth will be augmented in the forthcoming years. Genetics is currently one of the most dynamic sciences in medicine, and genetic data plays a vital role in all areas of medicine. Within a few years, technological advancements are converted from research to clinical testing, and there has been a significant increase in Direct to Consumer (DTC) genetic testing. The consumer receives results online, usually without a human interface or consultation, and later seeks professional advice.

Based on sector, the bioinformatics market is divided into medical biotechnology, animal biotechnology, agricultural biotechnology, academics, environmental biotechnology, forensic biotechnology, and others. The medical biotechnology segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period. The major driving factors for the growth of the sector segment are rising advancements and the growing demand for bioinformatics tools.

Regional Analysis:

Based on geography, the bioinformatics market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. North bioinformatics market has been analysed based on three major countries — the US, Canada, and Mexico. The US is estimated to hold the largest bioinformatics market share during the forecast period. The US government initiated various research programs to boost the genomic research, including the ‘All of Us Research Program’ led by NIH, which provided US$ 28.6 million in funding to develop three genome centers across the US. This research program will accelerate the precision medicine discoveries through Bioinformatics services in different institutions in the US. The supportive environment in the US accelerates the growth of the development and commercialization of pharmaceutical and biopharmaceutical products. The market players in the country received various patents for their innovations. Thus, the growing bioinformatics services and product launches for various genetic diseases and cancer studies in the pharmaceutical & biopharmaceutical industries will boost the Bioinformatics market growth. For instance, in June 2022, California’s biotechnology research startup LatchBio has introduced an end-to-end bioinformatics platform for handling big biotech data to accelerate scientific discovery. It allows biologists to organize data and run processes, bioinformaticians to upload new workflows, and computational biologists to do downstream analysis.

Asia Pacific accounted for the fastest-growing region in the global bioinformatics market and was projected to grow at a faster pace over the forecast period. The market in this region is largely held by countries such as China and Japan. The factors contributing to the growth of the bioinformatics market in these countries are advancements in the field of genomics and proteomics, generating massive volume of data, which is to be interpreted and managed.

Bioinformatics Market Trend:

Bioinformatics and AI are playing critical roles in changing and advancing the healthcare industry. In the context of bioinformatics, AI can be used to promote clinical research and analysis that can result in the design of new drugs and vaccines, the diagnosis of diseases, and even the prediction of pandemics. One example of how AI can be used in conjunction with bioinformatics is wearable tech. Consumers are already familiar with many types of wearable techs, such as fitness trackers and watches, and make personal use of the data they collect. The wearable tech provides real-time data over a period of time and can help track trends and identify signs of potentially fatal health issues, such as heart disease, much quicker and more accurately than spot tests conducted in laboratories. Also, genome sequencing plays a pivotal role in medical diagnostics. Machine learning empowered DNA sequencing techniques such as next-generation sequencing have made it possible for researchers to sequence human genomes within a day compared to the traditional sanger sequencing technology, which took over a decade to sequence a human genome. The integration of AI and machine learning in bioinformatics is showing the current trend in bioinformatics market.

Covid-19 Impact:

Bioinformatics market witnessed a positive impact due to increased demand for COVID-19 detection kits during the pandemic. At the biological level, SARS-CoV-2 and COVID-19 research involves high-throughput technologies such as Next-Generation Sequencing for detecting the genome of SARS-CoV-2, databases storing SARS-CoV-2 genomes and variants, bioinformatics software tools and databases for analyzing and storing host-virus interactions. At the medical level, the search for therapeutic strategies, the identification of COVID-19 biomarkers, the discovery of therapeutic targets for drugs, and the bioinformatics approaches for drug repurposing, i.e., the use of already available drugs for the COVID-19 disease, were the main research themes, which further escalated the market growth. Moreover, there has been an increase in the use of synthetic gene-based technologies for studying SAR-CoV-2 virulence and facilitating vaccine development.

The recent two decades' invention and advances in nucleic acid amplification technologies, automated DNA sequencing, and bioinformatics tools revolutionized the characterization and classification of all infectious disease agents. The rising incorporation of bioinformatics methodologies and technology into many areas of the worldwide response to the COVID-19 pandemic is yet another crucial and visible evidence of the essential bioinformatics role in modern science and medicine.

Bioinformatics Market Regional Insights

The regional trends and factors influencing the Bioinformatics Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Bioinformatics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

bioinformatics-market-global-geography
  • Get the Regional Specific Data for Bioinformatics Market

Bioinformatics Market Report Scope

Report Attribute Details
Market size in 2021 US$ 12.61 Billion
Market Size by 2028 US$ 34.75 Billion
Global CAGR (2021 - 2028) 15.7%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Bioinformatics Platforms
  • Knowledge Management Tools
  • Bio Informative Services
By Application
  • Genomics
  • Proteomics
  • Chemoinformatics & Drug Design
  • Transcriptomics
  • Metabolomics
By Sector
  • Medical Biotechnology
  • Animal Biotechnology
  • Agricultural Biotechnology
  • Academics
  • Environmental Biotechnology
  • Forensic Biotechnology
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Dassault Systèmes
  • Bruker Corporation
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • Illumina, Inc.
  • PerkinElmer Inc.
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Biomax Informatics AG

  • Bioinformatics Market Players Density: Understanding Its Impact on Business Dynamics

    The Bioinformatics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Bioinformatics Market are:

    1. Dassault Systèmes
    2. Bruker Corporation
    3. Agilent Technologies, Inc.
    4. Eurofins Scientific
    5. Illumina, Inc.

    Disclaimer: The companies listed above are not ranked in any particular order.


    bioinformatics-market-cagr

    • Get the Bioinformatics Market top key players overview

    Competitive Landscape and Key Companies:

    Some of the prominent players operating in the global bioinformatics market include Agilent Technologies, Inc, Biomax Informatics Ag, Bruker Corporation, Dassault Systems, Eurofins Scientific, Geneva Bioinformatics, Illumina, PerkinElmer, Qiagen, ThermoFisher Scientific, Inc. among others. These companies focus on new technologies, advancement in the existing products and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. For instance, in March 2020, Genesis Healthcare Co., Japan's leading genetic testing and research company, launched GenesisGaia's new genomic-data-marketplace tool for R &D in Japan to empower industry researchers by increasing their productivity in crucial applications such as accelerating drug discovery, clinical development, and precision medicine, as well as strengthening the development of personalized consumer products and services.

    In January 2021, Illumina, Inc. has transforming genomic data bottlenecks into catalysts with the launch of Illumina Connected Analytics (ICA). The new and integrated bioinformatics solution provides a comprehensive, private, cloud-based data platform that empowers customers to manage, analyze, and explore large volumes of multi-omic data in a secure, scalable, and flexible environment.


    Frequently Asked Questions

    Which sector held the largest share in the bioinformatics market?

    The medical biotechnology segment dominated the global bioinformatics market and held the largest market share of 29.18% in 2021.

    Which are the top companies that hold the market share in Bioinformatics market?

    Thermo Fisher Scientific and Agilent Technologies, Inc. are the top two companies that hold huge market shares in the bioinformatics market.

    Which region is expected to witness significant demand for bioinformatics market in the coming years?

    Global bioinformatics market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The North America region is the held the largest market for the bioinformatics market during the forecast period. The large share of North America is attributed to factors such as the presence of decreased cost of sequencing, leading bioinformatics providers, government support for genomic research, increased awareness of bioinformatics services, and increased number of genomic research activities in the region are driving the growth of the bioinformatics market in North America. Also, it has a favorable funding scenario for research activities.

    What is the market CAGR value of bioinformatics market during forecast period?

    The CAGR value of the bioinformatics market during the forecasted period of 2022-2028 is 15.7%.

    Which product led the bioinformatics market?

    The bioinformatics platforms segment held the largest market share of 48.47% in 2021 in the global bioinformatics market.

    What are the driving factors for the bioinformatics market across the globe?

    Key factors that are driving the growth of this market increasing funding and investments in bioinformatics and increased number of genomic research activities with the corresponding adoption of bioinformatics are expected to boost the market growth for bioinformatics over the years.

    Which application held the largest share in the bioinformatics market?

    The genomics segment dominated the global bioinformatics market and accounted for the largest market share of 28.33% in 2021.

    What is bioinformatics?

    Bioinformatics, as associated with genetics and genomics, is a scientific subdiscipline that involves using computer technology to collect, store, analyze and disseminate biological data and information, such as DNA and amino acid sequences or observations about those sequences. Bioinformatics is essential for the management of data in modern biology and medicine. Scientists and clinicians use databases that organize and guide biological information to increase the understanding of health and disease and, in certain cases, as part of medical care.

    Who are the key players in the bioinformatics market?

    The Bioinformatics market majorly consists of the players such as Agilent Technologies, Inc, Biomax Informatics Ag, Bruker Corporation, Dassault Systems, Eurofins Scientific, Geneva Bioinformatics, Illumina, Perkinelmer, Qiagen, Thermofisher Scientific, Inc. among others.

    What is the COVID 19 impact on the bioinformatics market in the coming years?

    The bioinformatics research during the COVID-19 pandemic has given an impulse to the development and adaption of various informatics techniques, including computational methods for tracing and tracking infected people, artificial intelligence methods and robotics applications to support remote patients assistance, collaborative data infrastructures for COVID-19 research and sentiment analysis methods for monitoring the impact of lockdown measures. The introduction of genomics and bioinformatics have contributed immensely to understand infectious disease from disease pathogenesis, mechanisms and the spread of antimicrobial resistance to host immune responses.

    Ankita Mittal
    Ankita Mittal
    Manager,
    Market Research & Consulting

    Ankita is a dynamic market research and consulting professional with over 8 years of experience across the technology, media, ICT, and electronics & semiconductor sectors. She has successfully led and delivered 100+ consulting and research assignments for global clients such as Microsoft, Oracle, NEC Corporation, SAP, KPMG, and Expeditors International. Her core competencies include market assessment, data analysis, forecasting, strategy formulation, competitive intelligence, and report writing.

    Ankita is adept at handling complete project cycles—from pre-sales proposal design and client discussions to post-sales delivery of actionable insights. She is skilled in managing cross-functional teams, structuring complex research modules, and aligning solutions with client-specific business goals. Her excellent communication, leadership, and presentation abilities have enabled her to consistently deliver value-driven outcomes in fast-paced and evolving market environments.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies - Bioinformatics Market

    1. Dassault Systèmes             
    2. Bruker Corporation            
    3. Agilent Technologies, Inc.                
    4. Eurofins Scientific                
    5. Illumina, Inc.         
    6. PerkinElmer Inc.                  
    7. QIAGEN    
    8. Thermo Fisher Scientific Inc.           
    9. Biomax Informatics AG     
    10. Genebio
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo